CSIMarket
 




Aimmune Therapeutics Inc   (AIMT)
Other Ticker:  
 
 



AIMT Price to Cash Flow Ratio (Jun 30 2020) (Mar 31 2020) (Dec 31 2019) (Sep 30 2019) (Jun 30 2019)
Cash Flow Trailing 12 Months II. Quarter I. Quarter IV. Quarter III. Quarter II. Quarter
Price to Cash Flow (TTM) Ratio current            11.59            6.65            6.65            6.65            6.65
Cashflow TTM Y / Y Change - % - % - % - % - %
Cashflow Y / Y Change - % - % - % - % - %
Stock performance to date 110.18 % -48.14 % 7.4 % 43.03 % -2.92 %

Price to Cash Flow ratio Comment
Company's current Price to Cash Flow ratio has increased due to shareprice growth of 110.18 %, from beginning of II. Quarter and due to Cash flow increase, to Price to Cash Flow of 11.59, from average Price to Cash Flow ratio in I. Quarter of 6.65.


What is Price to Cash Flow Ratio?
Valuation in Major Pharmaceutical Preparations Industry

Price to Cash Flow ratio Company Ranking
Within: No.
Industry #75
Sector #138
S&P 500 #619






Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com